3 RD PARTNERING WITH SUMMIT

Transcription

1 PRESENTS 3 RD PARTNERING WITH SUMMIT Identifying New Platforms, Tools, and Strategies to Assist Accountable Care Organizations in Reducing Costs, Improving Quality, and Increasing a Populations Care While Developing a Beneficial Cross-Industry Relationship TODD BERNER ASTELLAS ROBERT BRENNER SUMMIT MEDICAL GROUP LEARNING OBJECTIVES: MARK FULCO SISTERS OF PROVIDENCE HEALTH SYSTEMS KITTY RAJAGOPALAN SUNOVION Gain a better understanding of the accountable care marketplace and how the healthcare delivery system is changing for millions of patients Explore why a standard sales platform needs to be shifted into a noncommercial value-based partnership strategies when interacting with ACOs Hear directly from ACO executives on what they are looking for from an industry partner and how these partnerships can assist them in meeting CMS quality measurements Discover ways to develop value-based programs that would enhance efficiencies, improve patient outcomes, increase patient adherence, or improve quality of care Discover best practices and case studies on how to develop and implement a successful cross industry partnership SPONSORED BY BRENDA RADKE MEDICAL PRACTITIONERS FOR AFFORDABLE CARE PAM BAKER CARDIODX MARCH 18 19, 2014 THE INN AT PENN, A HILTON HOTEL PHILADELPHIA, PA Industry Leaders Representing: AMGEN ARIZONA SUN ASTELLAS BAYER BREVARD PHYSICIAN NETWORK BRISTOL-MYERS SQUIBB CARDIODX CATHOLIC MEDICAL PARTNERS COOPER UNIVERSITY HOSPITAL DURATA THERAPEUTICS FLORIDA PHYSICIANS TRUST ACOS GOLDENLIFE HEALTHCARE HUNTERDON HEALTHCARE PARTNERS MARTIN HEALTH SYSTEM MEDICAL PRACTITIONERS FOR AFFORDABLE CARE Don t OTSUKA Miss The Relationship with ACO PFIZER Board Room Dinner on Tuesday SISTERS March 18th OF PROVIDENCE at 6:00pm HEALTH SYSTEMS SUNOVION VERTEX PHARMACEUTICALS WALGREENS WEST FLORIDA ACO LLC

2 Dear Colleague, As the creator of The Partnering with ACO series I would like to invite you to our 3rd Partnering with ACO Summit this March 2014 in Philadelphia, PA. This year s meeting is designed as an educational platform that will allow the life science industry to explore the best practices in engaging with ACOs while developing a beneficial cross-industry relationship. As an industry we have been challenged to adapt to changes including new markets, regulations, product launches, and currently we are adapting our customer facing approach to Accountable Care Organizations. With the rapid growth of nearly 400+ ACOs currently operating in the US, industry is undergoing changes to assist these value-based healthcare systems. As a value-based healthcare system, ACOs are always looking for innovative platforms, services, and products that can assist them in increasing patient care, improving quality, increasing a population s care and in turn allowing them to share in the cost savings. With the success of ACOs, it s clear that industry needs to prepare for growth and change over the next few years. Success in this new healthcare delivery model results in how prepared an organization is in being able to alter from a standard sales approach to a non-commercial value-add partnership. The outcome of these partnership strategies is not only a strong relationship with an ACO, but a profitable revenue stream for a manufacturer. Currently some of the partnership platforms include data exchanges, health economics outcomes research, patient engagement, and many more. As these partnerships continue to develop, we are learning that it s much more than developing a partnership platform. It s about learning and understanding your customer in order to engage with them while demonstrating the value you can provide in meeting their goals. Returning for its second year the ACO Relationship Board Room Dinner will provide industry leaders with an intimate networking opportunity to hear from ACO executives on what they are looking for from manufacturers. I look forward to seeing you in Philadelphia, PA this March! Sincerely, Scott Grossman Director, Partnering with ACO Series WHO SHOULD ATTEND LIFE SCIENCES INDUSTRY Pricing & Reimbursement, Health Economics & Outcomes Research Account Management Brand/Product Management Organized/Managed Markets Sales & Marketing Medical Affairs, Medical Science Liaisons, Scientific Account Liaison Policy, Government Affairs Managed Care Evidence Based Medicine Team Leaders ACOs, HEALTH PLANS AND PHYSICIAN ORGANIZATIONS Executive Leadership Chief Medical Officers Medical Directors Quality and Care Directors Administrators Medicaid Managed Care Directors Company Profiles Pharmaceutical Medical Device Accountable Care Organizations Biotechnology Laboratory Service Providers Profiles Represented in Percentage Life Science Attendee Profiles INN AT PENN, A HILTON HOTEL 3600 Sansom Street, Philadelphia, PA Stay at The Inn at Penn, A Hilton Hotel; an AAA Four Diamond hotel situated in the heart of the University of Pennsylvania verdant, tree-lined campus. Enjoy beautifully-appointed Ivy League accommodations in the culturally rich and diverse neighborhood of University City, within easy walking distance of some of the nation s most prestigious medical, educational and corporate centers. Dine in style at the award-winning Penne Restaurant & Wine Bar, unwind in the Living Room Lounge, or maintain your fitness regime in our 24-hour fitness center. To make reservations please call and request the negotiated rate for ExL s 3rd ACOs. You may also visit: personalized/p/phlidhh-3rdp /index.jhtml to make reservations online. The group rate is available until February 24, Please book your room early as rooms available at this rate are limited Pricing, Reimbursement, Health Economics Outcomes Research Account Managers Organized/Managed Markets Sales and Marketing Brand/Product Management Policy/ Government Medical Affairs Profiles Represented in Percentage

3 DAY ONE TUESDAY MARCH 18, :00 REGISTRATION AND CONTINENTAL BREAKFAST 8:45 OPENING REMARKS TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC. MARK FULCO, Senior Vice President, Strategy and Marketing, SISTERS OF PROVIDENCE HEALTH SYSTEMS 9:00 ACO Executive Perspective: Recognize the Impact on Healthcare Markets, Emerging Trends, and Key Success Factors High level overview on US healthcare system Emerging trends in ACO s and commercial shared savings Key success factors for managing risk Examples from a large multi-specialty group Opportunity for Q&A and discussion ROBERT W. BRENNER, MD, MMM, Chief Medical Officer, SUMMIT MEDICAL GROUP 9:45 Industry Executive Perspective: Restructuring an Organizational in Order to Develop a Partnership to Working with ACOs though a Systematic Approach Evaluating the best way to engage with ACOs through need-based roadshow type market research interactions Understanding The ACO customer Model and approach to drug management or formulary Developing tools and tactics that fit ACO customer needs and manufacturers interests. Incorporating clinical marketing, pharmaeconomics, observational research, and other stakeholders to develop a value-based communication approach LAURENT CARTER, Executive Director Payer Segment & Value Marketing US Value and Access, AMGEN 10:30 Manufactures Role: Understanding the Important Role in the Uptake and Utilization of Emerging Models that Stakeholders Play in the ACO Landscape Understanding where manufactures fit in as a key stakeholder in the ACO environment Opportunities for innovative partnerships and new evidence generation Involvement in education and awareness of value Demonstrating how products and services improve clinical outcomes through HEOR-based studies Session Presented by XCENDA 11:00 NETWORKING BREAK 11:30 PARTNERSHIP CASE STUDY Working Together to Achieve Triple Aim Merging the healthcare and industry perspective together to enable better care at less cost Communication and demonstrating the value in an innovative diagnostic tests, devices and therapeutics that can assist increasing care Overview of the partnership built based off of shared interests between a life science organizations and an ACO Success of the partnership and impact on patient care and ACO quality PAM BAKER, Senior Director, Market Access, CARDIODX RAKESH PATEL, MD, Owner, ARIZONA SUN FAMILY MEDICINE, PC This summit gave me a new way of looking at the ACO marketing place DIRECTOR, HEALTH POINT 12:15 Accountable Care Organizations: What are the Opportunities and Risks Within This Emerging Customer Segment? Overview of emerging trends in Medicare, Medicaid, and commercial ACOs and the impact of ACOs on product, portfolio, and company as well as how ACO impact will vary across therapeutic categories. What do risk arrangements look like across ACO types in various segments? Who are the decision makers in these developing models? What are ACO goals for disease management in the nascent years of development? What strategies should industry develop to create collaborative relationships with ACOs BOB SHEWBROOKS, Principal, Practice Leader, HEATH STRATEGIES GROUP 1:00 LUNCHEON 2:00 Improving Outcomes: Data Sharing with Life Science to Improve Clinical Care Designing and implementing a data sharing platform Innovative strategies for delivering the best possible care Utilizing comparative effective research to successfully demonstrate a products value Understanding how data partnerships can transform healthcare delivery within an ACO Emphasizing on evidence-based care and on managing a population to a set of general costs and quality outcomes KITTY RAJAGOPLAN, Vice President, Health Economics Outcomes Research, SUNOVION 2:45 Heath Economics Outcomes Research: Collaborating with ACOs to Improve Patient Data New insights into the process of research evidence generation in support of value-based performance improvement for to increase the value of your product Learn the benefits of assembling a multi-stakeholder collaboration based on HEOR data to improve population health, patient s experience of care, and per capita costs Construct and implement a predictive market access model for the planned intervention utilizing evidence generated through the collaborative research process Explore best practices for assessing, disseminating, and applying the research collaboration generated evidence to ensure the advancement of successful of patient centered outcomes TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC. 3:30 NETWORKING BREAK 4:00 Supporting an ACO: Developing a Unified Organizational Strategy to Successfully Implement Strategic Collaborations Segmenting the marketplace and understanding what ACOs require from industry Educating an organization on the need for a unified approach to collaborate with ACOs Established an companywide definition of an ACO Understanding the contracting element to partnering with ACOs Developing a non-branded disease state education platforms with medical regulations and medical communication approval Implementing your strategic approach to ACOs ANDREW ERICKSON, MBA, Innovative Market Team Director, BAYER HEALTHCARE PHARMACEUTICALS 4:45 CO-CHAIRS CLOSING REMARKS 5:00 DAY ONE CONCLUDES

4 The ACO Relationship Board Room Dinner 6:00-9:00 Developing ways to Collaborate and Supply the Healthcare Marketplace With the rapid growth of ACOs and the increasing number of changes within healthcare system its clear that a traditional sales style will not work for ACOs. Instead, adapting a relationship style of partnering with your customers is now the preferred method, and is well received by ACO executives. By developing these sustainable relationships, manufactures will be able to develop a two-way dialogue where they can construct strategic platforms that will allow ACOs to improve quality, patient care, and improve a populations care. Some of the most common strategies are designed because ACOs are in need of outcomes data, clinical services, affective diagnostic testing, laboratories services and patient adherence support. However as every ACO is constructed differently there is not one preferred platform to provide value. It s important for you to understand how your customer is designed, functions, how patients are treated, and what value-add they are requiring. This exclusive dinner will allow participants the chance to network and start the relationship process with ACOs. The pre-dinner interactive panel session will feature ACO executives discussing the following: Overview of their organization Structure of their ACO Payment models Value-add needs How industry can provide value to their ACO Resources needed to execute a successful ACO BOARD ROOM DINNER LEADER: DAVID B. NASH, MD, MBA, Dean, JEFFERSON SCHOOL OF POPULATION HEALTH ACOs PARTICIPATING INCLUDE: Atrius Health Health Catalyst/TEAM of Brevard Physician Network Care Solutions Cooper University Hospital Hunterdon Healthcare Partners Goldenlife Healthcare Martin Health System Florida Physicians Trust ACOs Sisters of Providence Health Systems The Hackensack Alliance Summit Medical Group Accountable Care Organization Walgreens West Florida ACO LLC For additional information go to EXLPHARMA.COM/ACO *Limited seats available DAY TWO WEDNESDAY MARCH 19, :00 REGISTRATION AND CONTINENTAL BREAKFAST 9:00 DAY ONE RECAP TODD BERNER, MD, Director, Urology Health, Economics and Clinical Outcomes Research, Urology, ASTELLAS SCIENTIFIC AND MEDICAL AFFAIRS, INC. MARK FULCO, Senior Vice President, Strategy and Marketing, SISTERS OF PROVIDENCE HEALTH SYSTEMS 9:15 CASE STUDY Developing and Launching and Effective Patient Engagement Platform within an ACO Affectively developing a patient engagement platform within an ACO to successful engage patients Discovering ways to engage patients more affectively in healthcare delivery Developing a non-sales engagement structure with industry Working with life science educational divisions to assist in structuring these platforms Developing adherence arrangement around patient needs and disease states Allocating resources to fill this un-met cost need BRENDA RADKE, Executive Director, MEDICAL PRACTITIONERS FOR AFFORDABLE CARE 10:00 Impact of a Strategic ACO Pharmacy Program and Its Affect on Patient Care Identifying the pharmacy s role in accepting responsibility for cost and quality of care Increasing the impact of patient contact Shift from a strict acute-care focus to an ever-greater emphasis on preventive care Controlling costs and reimbursement pressure Reimbursement structure within an ACO through bundled payments, captivated arrangements, and shared savings Reallocation of pharmacy resources and talents Pharmacy s role in cost DAVID HARLOW, Chief Pharmacy Officer, MARTIN HEALTH SYSTEM 10:45 NETWORKING BREAK 11:15 Organization Change: Developing a Successful Plan for Partnering with an ACO Understanding the roles and goals of ACOs in the healthcare environment What are the expectations of ACOs How does industry develop strategies to meet the needs of the ACOs 12:00 LUNCHEON 1:00 ACOs and Bundled Payment Models: The New Reality for Providers and Life Sciences The evolution of payment reform and acceleration of initiatives by public and private payors ACA as a major catalyst for new payment and delivery reform models such as ACOs The shift in focus and incentives for providers in ACOs and bundled payment initiatives The impact of ACOs and the new payment initiatives on the development of value propositions by the Life Sciences ANDREW THORRENS, Head of Reimbursement and Market Access, DURATA THERAPEUTICS, INC. 1:45 Shifting Communication Approach s: Understanding and Engaging with your Customers to Expand Partnership Buy-In Understanding your customers: How ACOs see themselves and their mission Exploring the cost savings and patient quality structures ACOs work in Identifying ways to bring value to ACOs Adjusting your support strategies to facilitate your customers goals Developing platforms in which you can demonstrate value and develop collaborative partnerships that work for both industry and ACOs LON CASTLE, Medical Science Liaison, CARDIODX 2:30 Navigating the Value-Based Healthcare Environment: Developing an Organization Wide Approach to Understand the Changing Healthcare Delivery System and our Customers Understanding of ACOs and their impact on patient care Developing and gathering market research to develop a firm grasp of the ACO culture Analyzing market research to develop strategies for enhancing relationships with ACOs Developing customer engagement platforms strategies focused on strategic value collaboration LAUREN WALRATH, Director, Business Model Innovation and Commercial Operations, BRISTOL-MYERS SQUIBB 3:15 CLOSING REMARKS 3:30 SUMMIT CONCLUDES

5 FIVE WAYS PHONE: ONLINE: FAX: MAIL: ExL Events, Inc th Ave, 4th Floor New York, NY SPONSORSHIP AND EXHIBIT OPPORTUNITIES: Do you want to increase the brand awareness of your organizations solutions and services? Are you looking to meet potential clients who attend this event? PRICING FOR THE 3 RD PARTNERING WITH ACOs SUMMIT: EARLY BIRD PRICING Registering Before January 31, 2014 Life Science/Service Providers Summit & Board Room Dinner: $2495 Summit Only: $1895 ACOs, Health Plans/Systems, and Physician Organizations Summit & Board Room Dinner: $1495 Summit Only: $1295 STANDARD PRICING Registering After January 31, 2014 Life Science/Service Providers Summit & Board Room Dinner: $2695 Summit Only: $2095 ACOs, Health Plans/Systems, and Physician Organizations Summit & Board Room Dinner: $1695 Summit Only: $1495 For cancellation policy and group rates please visit: * Includes sales tax and service fees. TERMS & CONDITIONS: By registering for an ExL Events, Inc. ( ExL Pharma ) event, you agree to the following set of terms and conditions listed below: REGISTRATION FEE: The fee includes the conference all program materials and designated continental breakfasts lunches and refreshments. Group Discount Program: save 25% per person when registering Four. For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the program (must register 4 at one time) this is a savings of 25% per person. save 15% per person when registering three. Can only send three? you can still save 15% off of every registration. To find out more on how you can take advantage of these group discounts, please call PAYMENT: Must be received in full by the conference date. All discounts will be applied to the Conference Only fee (excluding add-ons) cannot be combined with any other offer and must be paid in full at the time of order. Group discounts available to individuals must be registered simultaneously and employed by the same organization. Cancellation and Refund Policy If you need to cancel your registration for an upcoming ExL event, please note the following policies derived from the Start Date of the event: Four weeks or more: A full refund (minus a $295 processing fee) or a voucher to another ExL event valid for 18 months from the voucher issue date. Less than four weeks: A voucher to another ExL event valid for 18 months from the voucher issue date If you cancel at any time after receiving the conference documentation, the voucher issued will be $395 less Substitution Charges: There will be an administrative charge of $300 to substitute, exchange and/ or replace attendee badges with a colleague occurring within five business days of the conference. ExL Pharma reserves the right to cancel any conference it deems necessary and will not be responsible for airfare hotel or any other costs incurred by registrants. ExL Pharma s liability is limited to the conference registration fee in the event of a cancellation and does not include changes in program date content speakers or venue * The opinions of ExL speakers do not necessarily reflect those of the companies they represent, nor ExL Events, Inc. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL Events, Inc. s ( ExL s ) designated speakers and is designed for informational purposes for its attendees, and is NOT INTENDED for purposes of copywriting, nor redistribution to other outlets without the express written permission of ExL s designated speaking parties. Neither ExL, nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS, INC. EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY THE CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of or endorse the views or opinions given by any third party content provider. ExL presentations may point to other Internet sites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites Take advantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExL works closely with you to customize a package that suits all of your needs. ACO BOARD ROOM RELATIONSHIP DINNER OPPORTUNTIES: Are looking looking to enrich your relationships and partnership opportunities? If so, ExL will be able to work closely with you to customize a package that allow you to gain additional exposure at this board room dinner. To learn more about these opportunities, contact Steve Decker, Senior Business Development Manger, at or sdecker@exlpharma.com. MEDIA PARTNERS: PM36O THE FULL SPECTRUM OF PRODUCT MANAGEMENT

6 PRESENTS 3 RD PARTNERING WITH ACOs SUMMIT Identifying New Platforms, Tools, and Strategies to Assist Accountable Care Organizations in Reducing Costs, Improving Quality, and Increasing a Populations Care While Developing a Beneficial Cross-Industry Relationship MARCH 18 19, 2014 THE INN AT PENN, A HILTON HOTEL PHILADELPHIA, PA